TheraRadar
← Back
Data updated: Mar 29, 2026

APOTHECON

Infectious DiseaseDermatologyCardiovascular
Specialty

APOTHECON is a specialty pharmaceutical company focused on Infectious Disease, Dermatology, Cardiovascular.

1950
Since
78
Drugs
-
Trials
230
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
KETOROLAC TROMETHAMINE 2026-01-22
Labeling
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE 2026-01-21
DILTIAZEM HYDROCHLORIDE 2026-01-18
Labeling
DILTIAZEM HYDROCHLORIDE 2025-11-14
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 33%
5 drugs
Dermatology 27%
4 drugs
Cardiovascular 20%
3 drugs
Gastroenterology 13%
2 drugs
Respiratory 7%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Dermatology, Respiratory
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular
BAUSCH specialty
Dermatology, Cardiovascular, Gastroenterology